We are live on ! Find out more
AXSM icon

Axsome Therapeutics
AXSM

244 hedge funds and large institutions have $3.12B invested in Axsome Therapeutics in 2023 Q4 according to their latest regulatory filings, with 44 funds opening new positions, 70 increasing their positions, 88 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

92% more call options, than puts

Call options by funds: $79.2M | Put options by funds: $41.4M

83% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 24

30% more funds holding in top 10

Funds holding in top 10: 10 → 13 (+3)

18% more capital invested

Capital invested by funds: $2.65B → $3.12B (+$473M)

8% more funds holding

Funds holding: 226 → 244 (+18)

2.6% more ownership

Funds ownership: 80.28% → 82.88% (+2.6%)

20% less repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 88

Holders
244
Holders Change
+18
Holders Change %
+7.96%
% of All Funds
3.56%
Holding in Top 10
13
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+30%
% of All Funds
0.19%
New
44
Increased
70
Reduced
88
Closed
24
Calls
$79.2M
Puts
$41.4M
Net Calls
+$37.9M
Net Calls Change
+$18.3M

Top Buyers

1
Morgan Stanley
Morgan Stanley
New York
+$62.9M
2
PA
Perceptive Advisors
New York
+$37.2M
3
Millennium Management
Millennium Management
New York
+$27.2M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$20.4M
5
BlackRock
BlackRock
New York
+$20.4M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$65.3M
2
NIP
Nicholas Investment Partners
California
-$20.9M
3
SCM
Soleus Capital Management
Connecticut
-$16.6M
4
Citadel Advisors
Citadel Advisors
Florida
-$13.8M
5
BI
BVF Inc
California
-$10M
Name Holding Trade Value Shares
Change 		Change in
Stake
MWM
101
Meridian Wealth Management
Kentucky
$1.63M +$85.2K +1,275 +7%
Wells Fargo
102
Wells Fargo
California
$1.56M +$48.4K +724 +4%
BNP Paribas Financial Markets
103
BNP Paribas Financial Markets
France
$1.55M -$486K -7,269 -27%
Wealth Enhancement Advisory Services
104
Wealth Enhancement Advisory Services
Minnesota
$1.51M +$1.26M +18,915 New
MIM
105
MetLife Investment Management
New Jersey
$1.47M – – –
GS
106
GTS Securities
New York
$1.46M +$718K +10,738 +142%
RJFSA
107
Raymond James Financial Services Advisors
Florida
$1.44M -$40K -598 -3%
CIBC Private Wealth Group
108
CIBC Private Wealth Group
Georgia
$1.43M +$9.03K +135 +0.8%
Mirae Asset Global Investments
109
Mirae Asset Global Investments
South Korea
$1.43M +$4.81K +72 +0.4%
AIG
110
American International Group
New York
$1.41M +$10.8K +162 +0.9%
CM
111
Caption Management
Oklahoma
$1.4M +$1.18M +17,600 New
SCM
112
Superstring Capital Management
New York
$1.29M +$1.08M +16,179 New
TD Asset Management
113
TD Asset Management
Ontario, Canada
$1.27M +$1.07M +16,000 New
Envestnet Asset Management
114
Envestnet Asset Management
Illinois
$1.24M -$23.1K -346 -2%
ORI
115
Oak Ridge Investments
Illinois
$1.23M -$169K -2,524 -14%
PAMP
116
Polar Asset Management Partners
Ontario, Canada
$1.23M – – –
Ensign Peak Advisors
117
Ensign Peak Advisors
Utah
$1.22M – – –
Group One Trading
118
Group One Trading
Illinois
$1.19M -$364K -5,441 -27%
GC
119
Guggenheim Capital
Illinois
$1.18M +$995K +14,880 New
Connor, Clark & Lunn Investment Management (CC&L)
120
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$1.14M +$959K +14,339 New
Janus Henderson Group
121
Janus Henderson Group
United Kingdom
$1.13M -$1.87K -28 -0.2%
ACM
122
Aquatic Capital Management
Illinois
$1.12M +$943K +14,100 New
DIA
123
Dana Investment Advisors
Wisconsin
$1.09M -$33.9K -507 -4%
KCM
124
Kennedy Capital Management
Missouri
$1.06M +$83.9K +1,255 +10%
Susquehanna International Group
125
Susquehanna International Group
Pennsylvania
$1.02M +$632K +9,453 +286%
3 4
5
6 7

AXSM Hedge Fund Activity: Q4 2023 in Review

244 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Axsome Therapeutics (AXSM) for Q4 2023, worth a combined $3.12B — up 18% from $2.65B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new AXSM positions and 24 closed out — a net gain of 20 holders — while 70 added to existing stakes and 88 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $62.9M. The largest seller was Fidelity Investments, cutting an estimated $65.3M.

  • 244 institutional investors held Axsome Therapeutics (AXSM) as of Q4 2023, up from 226 in Q3 2023.
  • Funds reported $3.12B of Axsome Therapeutics stock for Q4 2023, up 18% quarter-over-quarter.
  • 44 funds opened new Axsome Therapeutics positions in Q4 2023 and 24 closed out, a net change of +20 holders.
  • The largest Axsome Therapeutics buyer in Q4 2023 was Morgan Stanley, an estimated $62.9M added.
  • The largest Axsome Therapeutics seller in Q4 2023 was Fidelity Investments, an estimated $65.3M sold.

Based on aggregated 13F filings for Q4 2023.